LABVOLUTION 2019, 21 - 23 May


Logo MyCartis
Exhibition stand
Hall 20, Stand D40
Open Exhibition Grounds map

Company Data

MyCartis NV

Technologiepark 4
9052 Zwijnaarde


Mr. Wouter Laroy
VP Scientific Marketing
Mr. François Topin
SVP Strategic Planning
Mr. Nicolas Demierre
VP Business Development
Mr. Paul Ladestein
Show all Show less

Company profile

The big revolution in healthcare today is that we are finally realizing that we are all equal, but not identical, certainly not at a molecular level. MyCartis is convinced that the future of healthcare lies in personalization. Our goal is to deliver innovative solutions for fast and cost effective identification of a patient's specific signature of biomarkers in order to make more personal health decisions and improve quality of life. On our road to validate biomarkers on a larger scale, our intention is to build a bridge between research and medical practice by developing broadly available multiplexed biomarker solutions through technology (Evalution™) and bio-assays. The ability to quantify different types of markers on a single platform will help producing more comprehensive and coherent multiplex data sets.
MyCartis wants to help you to make your biomarkers a success.

'Collaborate to Innovate' is our motto and therefore we are looking forward to work with you.


Multiplexing technology: Evalution™

The multiplexing solution Evalution™ provides researchers and assay developers with an innovative solution to validate their biomarkers and to utilize and commercialize them. Evalution now provides anyone the opportunity to build robust and multiplex assays for their biomarkers and to easily measure more

Product categories

Stored items


Server communication error: Item could not be saved.